These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27616655)

  • 21. Outcomes of Pediatric Central Venous Access Device Placement With Concomitant Surgical Procedures.
    Bludevich BM; Chandler NM; Gonzalez R; Danielson PD; Snyder CW
    J Surg Res; 2021 Mar; 259():451-457. PubMed ID: 33616076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
    Yamaguchi RS; Noritomi DT; Degaspare NV; Muñoz GOC; Porto APM; Costa SF; Ranzani OT
    Intensive Care Med; 2017 Aug; 43(8):1097-1104. PubMed ID: 28584925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel risk factors for central-line associated bloodstream infections in critically ill children.
    Woods-Hill CZ; Srinivasan L; Schriver E; Haj-Hassan T; Bezpalko O; Sammons JS
    Infect Control Hosp Epidemiol; 2020 Jan; 41(1):67-72. PubMed ID: 31685049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central line-associated bloodstream infection in neonatal intensive care units.
    Blanchard AC; Fortin E; Rocher I; Moore DL; Frenette C; Tremblay C; Quach C
    Infect Control Hosp Epidemiol; 2013 Nov; 34(11):1167-73. PubMed ID: 24113600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central Line-Associated Bloodstream Infections in Children With Hematologic and Oncologic Diseases: First Prevalence Results From a University Hospital.
    Özalp Gerçeker G; Yardımcı F; Aydınok Y
    J Pediatr Oncol Nurs; 2019; 36(5):327-336. PubMed ID: 31027430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients.
    Kelly M; Conway M; Wirth K; Potter-Bynoe G; Billett AL; Sandora TJ
    Infect Control Hosp Epidemiol; 2011 Nov; 32(11):1079-85. PubMed ID: 22011534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenging the 48-Hour Rule-Out for Central Line-Associated Bloodstream Infections in the Pediatric Intestinal Failure Population: A Retrospective Pilot Study.
    Chang MI; Carlson SJ; Nandivada P; O'Loughlin AA; Potemkin AK; Cowan E; Mitchell PD; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2016 May; 40(4):567-73. PubMed ID: 25567785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central line-associated bloodstream infection rate elevation: Attributable to National Healthcare Safety Network surveillance definition changes, ongoing opportunities for infection prevention, or both?
    Corley A; Cantara M; Gardner J; Trexler P; Rock C; Maragakis LL
    Am J Infect Control; 2017 Sep; 45(9):1030-1032. PubMed ID: 28736032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid cycle development of a multifactorial intervention achieved sustained reductions in central line-associated bloodstream infections in haematology oncology units at a children's hospital: a time series analysis.
    Dandoy CE; Hausfeld J; Flesch L; Hawkins D; Demmel K; Best D; Osterkamp E; Bracke T; Nagarajan R; Jodele S; Holt J; Giaccone MJ; Davies SM; Kotagal U; Simmons J
    BMJ Qual Saf; 2016 Aug; 25(8):633-43. PubMed ID: 26608456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric Ambulatory Central Line-Associated Bloodstream Infections.
    Rinke ML; Heo M; Saiman L; Bundy DG; Rosenberg RE; DeLaMora P; Rabin B; Zachariah P; Mirhaji P; Ford WJH; Obaro-Best O; Drasher M; Klein E; Peshansky A; Oyeku SO
    Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33386333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining incidence, risk factors, and impact on survival of central line-associated blood stream infections following hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.
    Lukenbill J; Rybicki L; Sekeres MA; Zaman MO; Copelan A; Haddad H; Fraser T; DiGiorgio MJ; Hanna R; Duong H; Hill B; Kalaycio M; Sobecks R; Bolwell B; Copelan E
    Biol Blood Marrow Transplant; 2013 May; 19(5):720-4. PubMed ID: 23380342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for vascular catheter-related bloodstream infections in pediatric intensive care units.
    Torre FPF; Baldanzi G; Troster EJ
    Rev Bras Ter Intensiva; 2018; 30(4):436-442. PubMed ID: 30672969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central-line associated bloodstream infections in a tertiary care children's University hospital: a prospective study.
    Venturini E; Montagnani C; Benni A; Becciani S; Biermann KP; De Masi S; Chiappini E; de Martino M; Galli L;
    BMC Infect Dis; 2016 Dec; 16(1):725. PubMed ID: 27903240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low Risk of Central Line-associated Bloodstream Infections in Pediatric Hematology/Oncology Patients.
    Kristinsdottir I; Haraldsson A; Gudlaugsson O; Thors V
    Pediatr Infect Dis J; 2021 Sep; 40(9):827-831. PubMed ID: 33990520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central line-associated bloodstream infections among critically-ill patients in the era of bundle care.
    Lin KY; Cheng A; Chang YC; Hung MC; Wang JT; Sheng WH; Hseuh PR; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2017 Jun; 50(3):339-348. PubMed ID: 26316008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results.
    Bundy DG; Gaur AH; Billett AL; He B; Colantuoni EA; Miller MR;
    Pediatrics; 2014 Dec; 134(6):e1678-85. PubMed ID: 25404721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreasing central line associated bloodstream infection in neonatal intensive care.
    Powers RJ; Wirtschafter DW
    Clin Perinatol; 2010 Mar; 37(1):247-72. PubMed ID: 20363458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiology and risk factors for central line-associated bloodstream infections among pediatric oncology outpatients: a single institution experience of 41 cases.
    Kelly MS; Conway M; Wirth KE; Potter-Bynoe G; Billett AL; Sandora TJ
    J Pediatr Hematol Oncol; 2013 Mar; 35(2):e71-6. PubMed ID: 23412591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence, classification, and risk stratification for Candida central line-associated bloodstream infections in pediatric patients at a tertiary care children's hospital, 2000-2010.
    Klatte JM; Newland JG; Jackson MA
    Infect Control Hosp Epidemiol; 2013 Dec; 34(12):1266-71. PubMed ID: 24225611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors predicting the cause and prognosis of central line-associated bloodstream infections.
    Nemoto T; Kunishima H; Shimizu G; Hirose M; Yamasaki Y; Nishisako H; Takagi T; Matsuda T
    J Infect Chemother; 2015 Feb; 21(2):118-22. PubMed ID: 25483264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.